The Council Blasts Safe Cosmetics Act of 2010
The Personal Care Product Council issued a targeted response to the Safe Cosmetics Act of 2010 introduced in Congress by Representatives Jan Schakowsky (D-IL), Edward Markey (D-MA) and Tammy Baldwin (D-WI).
“We are concerned that the Safe Cosmetics Act of 2010 as written is not based on credible and established scientific principles, would put an enormous if not impossible burden on FDA, and would create a mammoth new regulatory structure for cosmetics, parts of which would far exceed that of any other FDA-regulated product category including food or drugs. The measures the bill would mandate are likely unachievable even with the addition of hundreds of additional FDA scientists and millions more in funding and would not make a meaningful contribution to product safety.”
The Council’s plan includes the following five elements:
1. Enhanced FDA Registration. It requires that personal care products manufacturers comply with the following:
• Register with FDA all facilities where those products are manufactured.
• File with FDA product ingredient reports disclosing all of the ingredients used in those products; and
• Report to FDA any serious unexpected adverse event with a personal care product experienced by consumers.
2. New Process to Set Safety Levels for Trace Constituents. When requested or on its own initiative, FDA would be required to establish safe levels for trace constituents in cosmetic ingredients and products.
3. New FDA Ingredient Review Process. Once a request has been made, or FDA unilaterally determines action is warranted, the agency would be required to review the safety of any ingredient intended for use in a personal care product and set safety use levels for such ingredient on a specified timetable.
4. New FDA Oversight of CIR Findings. FDA would be required to review current and future findings on the safety of cosmetic ingredients by the Cosmetic Ingredient Review (CIR) Expert Panel and determine if these findings are correct. If there are instances in which it determines a CIR finding is not correct, FDA would determine by guidance or regulations if, or under what conditions, the ingredient can be used safely in personal care products.
5. FDA-Issued Good Manufacturing Practices. FDA would establish industry-wide “Good Manufacturing Practices”requirements.
IFRA Refutes Claims Linking Health Problems to Fragrance
The International Fragrance Association (IFRA) has refuted a report linking fragrance ingredients to health problems. According to IFRA, the release by the Cancer Prevention Coalition makes inaccurate statements regarding the fragrance industry’s global IFRA Safety Program.
IFRA set up a global safety program in 1973. It involves the industry assessing the safety of materials and either banning them or setting so-called “Safe Use Levels” based on the review of studies of potential effects.The scientific program led by the Research Institute for Fragrance Materials (RIFM) has been active since 1966.
|Promotions and a New Hire at ACI
The American Cleaning Institute (ACI), formerly The Soap and Detergent Association, named Jacob Cassady as its new manager, government affairs, and announced the promotions of two of its directors, Douglas Troutman and Paul DeLeo.
Cassady joins ACI from the National Active and Retired Federal Employees Association (NARFE), where he was a legislative specialist. The Minnesota native previously worked on Capitol Hill and served as an aide on the House Agriculture Committee.
ACI also recently announced the promotions of Douglas Trout man to senior director, government affairs and Dr. Paul DeLeo to senior director, environmental safety.
Prior to joining ACI in 2007, Troutman served as senior manager, legislative affairs at Underwriters Laboratories (UL) Inc. and at the National Electrical Manufacturers Association in Arlington, VA.
Also joining ACI in 2007, DeLeo was previously a consumer safety officer for the U.S. Food and Drug Administration (FDA).